Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "MIT"

6593 News Found

Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice
Healthcare | April 17, 2026

Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice

4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration


Experts push for preventive, equitable haemophilia care at IHC X Summit
Healthcare | April 17, 2026

Experts push for preventive, equitable haemophilia care at IHC X Summit

The national platform brought together healthcare professionals, patient advocates, and stakeholders


ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role
Biopharma | April 13, 2026

ICPA to host India Unlimited 4.0 in San Diego to spotlight India’s global biopharma role

This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing


Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
News | April 11, 2026

Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE

Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter


Mitsui Chemicals unveils world’s first device for continuous bile excretion in lab-grown liver cells
Medical Device | April 03, 2026

Mitsui Chemicals unveils world’s first device for continuous bile excretion in lab-grown liver cells

The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells


AbbVie stakes claim to redefine skin disease treatment at Global Dermatology Summit
R&D | March 28, 2026

AbbVie stakes claim to redefine skin disease treatment at Global Dermatology Summit

Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims


CuraTeQ Biologics enters into agreement with STADA Arzneimittel AG
News | March 27, 2026

CuraTeQ Biologics enters into agreement with STADA Arzneimittel AG

STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories


LGM Pharma commits $15M to US facilities in major CDMO expansion
News | March 23, 2026

LGM Pharma commits $15M to US facilities in major CDMO expansion

This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing


India tackles rare diseases head-on at landmark summit in New Delhi
News | March 12, 2026

India tackles rare diseases head-on at landmark summit in New Delhi

Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration


Sumitomo Pharma bags world-first go-ahead for iPS cell therapy to treat Parkinson’s disease
News | March 10, 2026

Sumitomo Pharma bags world-first go-ahead for iPS cell therapy to treat Parkinson’s disease

The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%